The role of advanced data technologies in reducing hurdles.
Andy Studna
Advertisement
Andy Studna is an editor for Applied Clinical Trials, an MJH Life Sciences sister publication.
Articles by Andy Studna
In the second of MJH Life Sciences' State of the Physician reports, over 1,600 respondents weighed in on how they have been affected financially by COVID-19 and what it means for them moving forward.
A new series of surveys has been released by MJH titled State of the Physician. The first focuses on how physicians are communicating with their patients during COVID-19.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
5
